NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for BOLT

Based on 2 analysts offering 12 month price targets for Bolt Biotherapeutics Inc

Min Forecast
$20.00+272.44%
Avg Forecast
$50.00+831.1%
Max Forecast
$80.00+1,389.76%

Should I buy or sell BOLT stock?

Based on 2 analysts offering ratings for Bolt Biotherapeutics Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BOLT stock forecasts and price targets.

BOLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-20
lockedlocked$00.00+00.00%2025-05-13

1 of 1

BOLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BOLT$5.37$50.00+831.10%Buy
BGMS$4.59N/AN/A
PCSA$0.21$1.00+383.09%Buy
NBY$1.75N/AN/A
EVGN$1.21$3.50+190.46%Strong Buy

Bolt Biotherapeutics Stock Forecast FAQ

Is Bolt Biotherapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BOLT) stock is to Buy BOLT stock.

Out of 2 analysts, 1 (50%) are recommending BOLT as a Strong Buy, 0 (0%) are recommending BOLT as a Buy, 1 (50%) are recommending BOLT as a Hold, 0 (0%) are recommending BOLT as a Sell, and 0 (0%) are recommending BOLT as a Strong Sell.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.

What is BOLT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BOLT price target, the average BOLT price target is $50.00, with the highest BOLT stock price forecast at $80.00 and the lowest BOLT stock price forecast at $20.00.

On average, Wall Street analysts predict that Bolt Biotherapeutics's share price could reach $50.00 by May 20, 2026. The average Bolt Biotherapeutics stock price prediction forecasts a potential upside of 831.1% from the current BOLT share price of $5.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.